Impact of specific mutant KRAS on clinical outcome of EGFR-TKI-treated advanced non-small cell lung cancer patients with an EGFR wild type genotypeGiulio Metro, Lucio Crinò, Matthias Fischer et al.|Lung Cancer|2012Cited by 70
Carboplatin plus pemetrexed for platinum-pretreated, advanced non-small cell lung cancer: a retrospective study with pharmacogenetic evaluationGiulio Metro, Lucio Crinò, Rita Chiari et al.|Cancer Chemotherapy and Pharmacology|2011Cited by 19